Nitric Acid

Nitric Acid

SCHEMBL8957391

O=[N+]([O-])O.O=[N+]([O-])O.OCCC1CCC(CCO)CC1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
ESR2 Q92731 2/20 0.39
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
BRD4 O60885 1/20 0.32
LMNA P02545 1/20 0.32
CSF1R P07333 1/20 0.32
TYMP P19971 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL8957431 0.89 HPGD (0.37) CA5ACA5BESR2ALDH1A1TDP1
SCHEMBL5733 0.81
SCHEMBL24197652 0.81 ESR2 (0.50) ESR2BRD4TYMP
SCHEMBL240852 0.81 ESR2 (0.50) ESR2BRD4TYMP
Nitric Acid SCHEMBL9874935 0.79 CA5A (0.44) CA5ACA5BESR2ALDH1A1TDP1
Nitric Acid SCHEMBL9766393 0.73 EPHX1 (0.36) CA5ACA5BALDH1A1TDP1
SCHEMBL899402 0.73 ESR2 (0.45) ESR2BRD4
SCHEMBL21110513 0.73 ESR2 (0.45) ESR2BRD4TYMP
SCHEMBL760537 0.73 ESR2 (0.45) ESR2BRD4TYMP
SCHEMBL15842184 0.73 ESR2 (0.53) ESR2BRD4TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed